Houston Methodist Academic Institute
NEWSLETTER
June 2022
result
result
Houston Methodist Awards $4.6 Million Through Its Diversity, Equity & Inclusion Grant Program
Houston Methodist announced that it has awarded more than $4.6 million in community grants to 59 Houston-area nonprofit organizations through the Houston Methodist Diversity, Equity & Inclusion Grant Program. This program supports community initiatives focused on addressing the social determinants of health that lead to health inequities within racial, ethnic and social minorities, including women, people experiencing homelessness, older adults, the LGBTQ+ community, immigrants and more.
Now in its second year, the DEI Grant Program will support more than 100,000 people in the Greater Houston area through 29 healthy neighborhood programs, 16 economic empowerment programs and 17 educational empowerment programs. The program includes two types of grant funding — the Social Equity Grant awards funding for health equity programs targeting racial and ethnic minorities and the DEI Grant provides resources for operating and capacity building for agencies serving broader minority communities. Since the program was launched in 2021, an additional 22 organizations received grants, resulting in an 87% increase in funds awarded this year.
In addition to the DEI Grant Program, Houston Methodist has a Community Benefits Grant Program that offers grant support to local nonprofits working to provide affordable, quality access to health care and mental health services to the financially indigent. To learn about the 2022-2023 DEI and Social Equity grant awardees, click here.
Digital Methodology
Researchers at Houston Methodist have validated a battery of preclinical behavioral tests that can facilitate investigating the underpinnings of neurocognitive deficits after a subarachnoid hemorrhage. Read more in digital Methodology.
Announcements
Early registration fees, submissions for Community Connect and Youth4LungHealth & more
The Union World Conference on Lung Health 2022 will take place virtually from Nov. 8-11. You can register here.
Session submissions for Community Connect are open until June 20 and Creative session submissions are open until Aug. 15 in the following tracks:
- Community rights, gender and stigma
- COVID-19 – Lessons learned to strengthen the TB response
- Political environments for community-led advocacy and accountability
- Driving innovation and equitable access to new tools
George and Angelina Kostas Research Center for Cardiovascular Nanomedicine
“The New Frontier of RNA Nanotherapeutics” meeting, presented by the George and Angelina Kostas Research Center for Cardiovascular Nanomedicine, will feature a discussion on the events that led to the RNA vaccine breakthrough and preview emerging RNA Nanotherapeutics. Advances in the design of RNA constructs to improve stability and translational efficiency will be presented along with the leading-edge developments in nanomedicine to improve delivery and tissue specificity. The hybrid conference will be Monday, Oct. 24, 2022, from 9 a.m. - 5 p.m.
Register at: https://learn.houstonmethodist.org/content/kostas-2022
Praying for each other
Every week, the Prayer Connect Team at Houston Methodist Hospital sends an email with prayer requests. About 160 Methodist employees have committed to pray for requests from our colleagues and community.
We believe that staying connected is vital to our well-being, so please consider joining the chaplains in this initiative. If you would like to join us in praying for the requests of our employees and community, please reply to this email or contact Michela deTranaltes, Project Specialist for Grace Ministries, so we can add you to our confidential online community.
If you would like to submit a prayer, either text PRAYER to 45991 or email HMHPrayerRequest@houstonmethodist.org.
Hang Ten: Employee Support Group
Hang Ten provides a safe and confidential environment for mutual support. A chaplain will facilitate the group and introduce life tools such as mindfulness, intentionality and reframing.
Each session will stand alone, so feel free to log on any week for as long as your time permits. The group meets every Tuesday from noon to 1 p.m. Click here to join the recurring meeting.
Accolades
The Muscular Dystrophy Association awarded world-renowned ALS researcher and clinician Stanley H. Appel, MD, the 2022 MDA Tribute Award in Houston on June 2, Lou Gehrig Day, in acknowledgment of his work in pioneering ALS research and care and to celebrate the 40th anniversary of the Houston Methodist Neurological Institute's MDA ALS Research and Clinical Center.
At the American Transplant Congress (ATC), Osama Gaber, MD, delivered his vision for the future of transplantation –a patient-centered environment that maximizes patient outcomes by increasing organ availability and utilization by promoting innovation. ATC is the Joint Annual Meeting of the American Society of Transplant Surgeons and the American Society of Transplantation. It provides a forum for exchange of new scientific and clinical information relevant to solid organ and tissue transplantation and brings together transplant physicians, scientists, nurses, organ procurement personnel, pharmacists, allied health professionals and other transplant professionals.
NIH News
Hot Off the Presses: Updated RPPR Instruction Guide Available
An updated RPPR Instruction Guide is now available. The instruction guide reflects changes associated with recently issued guide notices on Other Support and Biosketch format pages, human subjects, Trainee Diversity Report and NRSA childcare costs reporting.
Watch
Videos on Watch
Treating and Preventing Chronic Metabolic Disease: An Introduction to Lifestyle Medicine and Establishing its Place in Traditional Health Care
Chronic disease is the leading cause of death and disability in the US. Lifestyle medicine is a medical approach that uses evidence-based behavioral interventions to prevent, treat and manage chronic disease.
Click here to watch.
11th Annual Nantz National Alzheimer Center Symposium Plasma Biomarkers and New Treatments for Alzheimer’s Disease and Related Disorders
The Nantz National Alzheimer Center symposium will examine the striking advances made in the identification of plasma biomarkers for Alzheimer’s disease and related disorders. Plasma biomarkers will allow for the identification of people at risk and, likely, for measuring the speed of disease progression. Thus, they will be critical in clinical trials and for the application of new therapies.
Click here to watch.
Inaugural Colorectal Cancer Updates for Primary Care
Colorectal cancer is the third-most-common cancer in the United States and the third-leading cause of cancer deaths. Of note, colorectal cancer rates are rising rapidly among young adults. Primary care providers play an important role in colorectal cancer prevention and are often called upon to provide care to colorectal cancer patients during and after their treatment.
Click here to watch.
In the Media
S. Wesley Long, MD, PhD, was interviewed for an Associated Press article on the latest omicron variant containing a delta mutation. The AP story was picked up by 1,240 media outlets. Long was also interviewed by the New York Times for an article offering guidance on safety measures the community should employ to help lessen the severity of the Covid surge beginning to emerge in Houston as signaled by wastewater levels.
Alysia Robichau, MD, was quoted in the New York Times in an article discussing ankle exercises that can be used to help strengthen and prevent injury.
DEI Spotlight
Recognizing the Impact of Microaggressions-For Leaders
The Office of Diversity, Equity & Inclusion (DEI) is excited to announce the newest DEI training course: Recognizing the Impact of Microaggressions. Microaggressions can lead to strained relationships and breakdowns in trust, as well as present barriers to promoting inclusivity.
This engaging, non-judgmental session will help you learn about microaggressions and provide tools to create inclusive language and enhance positive interactions. It will certainly ignite powerful discussions, stimulate awareness and promote positive change.
This 1-hour, 15-minute training is currently available only to leaders and key stakeholders prior to its July 2022 systemwide release. Leaders can register in LMS by searching DEI or contact DEITraining@houstonmethodist.org to request a group session.
Building Stronger Teams
Are you familiar with the “I Am,” “Flower Petals” or “Circle of Trust” group DEI activities? Visit the DEI Toolkit to find how these innovative, fun and engaging exercises can help strengthen the bonds within your workplace unit.
Caring for the Transgender Patient
June’s designation as Pride Month seeks to raise awareness to a number of issues confronting the LGBTQ+ community, including barriers many face in receiving equitable access to health care services. Click here to view a recording of a virtual session presented by the LGBTQ+ Allies ERG on how to provide culturally sensitive care and use appropriate vocabulary to improve the patient-provider relationship and decrease health care disparities for transgender patients.
Did You Know!
June’s designation as Caribbean American Heritage Month offers a great opportunity to learn more about the region. The Caribbean Islands form a massive archipelago located in the Caribbean Sea. It can be subdivided into several regions: the Lucayan Archipelago, the Greater Antilles, the Lesser Antilles and the ABC Islands. There are 13 sovereign states and 17 dependent territories in the Caribbean. The predominant languages spoken are English, Spanish, French, Dutch and Antillean creole.
Source: Caribbeanislands.com
Job Postings
We have several job openings in the Academic Institute. Click here to find one that interests you, or if you know of someone who might be interested.
New Employees
We welcome these new employees who joined the Academic Institute in December 2021.
- Nadia Ali, Contracts Administration, Sr Research Contract Analyst
- Alma Amaya, Infectious Disease – Musser, Research Assistant I
- Taelor Bridgewater, Transplant – Admin, Sr Academic Coordinator
- Danita Carey, Grants Administration, ACM Grant Specialist
- Olivia Casner, Education – CNREP, Student Professional Nurse
- Grace Cochran, Education – CNREP, Student Professional Nurse
- Cristina Coronel, Cancer Clinical Trials, Research Coordinator II
- Simone Covington, Education – CNREP, Student Professional Nurse
- Sayra Dilmac, Nanomedicine Research, Postdoctoral Fellow 2
- Ivan Dolotina, Education – CNREP, Student Professional Nurse
- Adib Edilbi, Orthopedics – Taraballi, Research Assistant I
- Amber Fairley, AOCT Operations – HMH, Clinical Research Nurse
- Rebecca Faulhaber, Education – CNREP, Student Professional Nurse
- Caroline Fowler, Education – CNREP, Student Professional Nurse
- Katie Gill, CCAT – Main, Clinical Research Nurse
- Jule Goike, Infectious Disease – Gollihar, ACM Research Associate I
- Daniel Gorelik, ENT - Takashima, Research Asst III
- Eva Gonzales, Infectious Disease – Arias, Sr Academic Coordinator
- Adriana Guerrero, Education – CNREP, Student Professional Nurse
- Nikita Gupta, Nanomedicine, Postdoctoral Fellow 0
- Abbie Johnson, CV Regeneration – Cooke, Research Assistant I
- Merrit Jones, Education – CNREP, Student Professional Nurse
- Nermin Kahraman, Nanomedicine Research, Supv Research Laboratory
- Göknur Kara, Nanomedicine Research, Postdoctoral Fellow 2
- Jonathan Lucas, Breast Oncology, Research Technician I
- Xin Li, Cancer - Yong Lu, Postdoctoral Fellow 0
- Chenyu Lin, Education – CNREP, Student Professional Nurse
- Angelica Lopez, Education - GME, Program Manager
- Mica Gabrielle Mangibin, Neurology – Masdeu, Clinical Research Nurse
- Deirdra Mantia, Education – CNREP, Student Professional Nurse
- Ellen Megerson, RNA Therapeutics – Brannan, Research Assistant I
- Padmaja Naik, Structural Heart Dis_Interv, Research Coordinator I
- Truc Nguyen, MRI Core Laboratory, Clinical Research Nurse
- Eleanor Nichols, Infectious Disease – Musser, Research Assistant I
- Hana Ngai, Education – CNREP, Student Professional Nurse
- Bulent Ozpolat, Nanomedicine Research, RI Scientist
- Andrea Franco Pandom, Neurology – Masdeu, Postdoctoral Fellow 0
- Lydia Pouga, Infectious Disease – Musser, ACM Research Associate II
- Danielle Rhodes, Education – CNREP, Student Professional Nurse
- Noor Al Saadi, Cancer Clinical Trials, Clinical Rsch Spclst
- Khalil Al-Salman, Dir Imaging Informatics & AI, Radiology Research Admin
- Annie Shupak, Education – CME, Continuing Med Edu Coordinator
- Madison Simmons, Education – CNREP, Student Professional Nurse
- Lori Smith, Education – CNREP, Student Professional Nurse
- Hadyn Solomon, Cyclotron, cGMP Specialist
- Beverly Swanson, Education – CNREP, Sr Administrative Assistant
- Abigail Thurman, Education – CNREP, Student Professional Nurse
- Allison Torres, Education – CNREP, Student Professional Nurse
- Megan Tragesser, Education – CNREP, Student Professional Nurse
- Deena Victor, Structural Heart Dis_Interv, Clinical Research Nurse
- Lindsay Young, Education – CNREP, Student Professional Nurse
Policy Reminders
BP in Practice is an educational reminder designed to raise awareness regarding Business Practices hot topics, relevant laws and policies & procedures. Find archives of BP in Practice here. If you have questions, contact the BP EthicsLine at 800.500.0333 or visit tmhs.myethicsline.com.
Publications
Outcomes of Mitral Valve Interventions Among Patients with Prior Mediastinal Radiation
Elbadawi, A., Mahtta, D., Assaf, Y., Albaeni, A., Saleh, A., Goel, S. S., Villablanca, P. A., Cornwell, L. D., Ghanta, R. K., Kayani, W., Kapadia, S. R., & Jneid, H. (2022). JACC: Cardiovascular Interventions, 15(1), 115-117. https://doi.org/10.1016/j.jcin.2021.09.022
Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms
El Haddad, L., Hanson, B. M., Arias, C. A., Ghantoji, S. S., Harb, C. P., Stibich, M., & Chemaly, R. F. (2021). Clinical Infectious Diseases, 73(12), 2306-2313. https://doi.org/10.1093/cid/ciab001
A novel fragmented mitochondrial genome in the protist pathogen Toxoplasma gondii and related tissue coccidia
Namasivayam, S., Baptista, R. P., Xiao, W., Hall, E. M., Doggett, J. S., Troell, K., & Kissinger, J. C. (2021). Genome Research, 31(5), 852-865. https://doi.org/10.1101/GR.266403.120
Aptamer-armed nanostructures improve the chemotherapy outcome of triple-negative breast cancer
Wan, Q., Zeng, Z., Qi, J., Chen, Z., Liu, X., & Zu, Y. (Accepted/In press). Molecular Therapy. https://doi.org/10.1016/j.ymthe.2022.02.004
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development for the Healey ALS Platform Trial Study Group.
HEALEY ALS Platform Trial Study Group, Biostatisticians, Investigators, Clinical Operations Team, & Medical Monitors (2022). Annals of Neurology, 91(2), 165-175. https://doi.org/10.1002/ana.26285
If you have a featured publication, for example on a journal cover, please let us know so we can include it in our next issue.
Funding Opportunities
Houston Methodist Neal Cancer Center Innovation Award Request for Applications
Key Dates
RFA Release Date:
May 10, 2022
Submission Deadline:
July 15, 2022
Funding Start Date:
Sept. 1, 2022
Funding Opportunity Overview
The goal of this Request for Applications is to provide pilot-funding for team-based, multi-PI research projects. If approved, funding is expected to support the formation of new cancer-focused activities with the potential to compete for NCI Program Project (P01), SPORE, and/or R01 equivalent funding within the next two years.
A P01 is a broadly based, multidisciplinary, often long-term research program that has a specific major objective or a basic theme. A program project generally involves the organized efforts of relatively large groups, members of which are conducting research projects designed to elucidate the various aspects or components of this objective.
Eligibility Information
Clinical, basic science, and/or translational research proposals will be accepted. Eligible principal investigators (PIs) include any Houston Methodist Neal Cancer Center Research Member or Associate Member.
Non-independent investigators (e.g., research associates, instructors, post-doctoral fellows, residents, and graduate students) are not eligible to apply as PI but can be included as co-investigators. More than one application from an investigator may be submitted. If you have received an HMNCC grant award in the last three (3) years you are not eligible to apply as the primary/contact PI but can be included on multi-PI proposals.
Funding Information
Applicants may propose a project funding period of up to 2 years with a maximum budget of $100,000 ($50,000/year). Funding for Year 2 will only be granted after satisfactory submission and review of Year 1 progress report. Awarded projects are not renewable beyond the 2 years. Applicants are required to describe a clear strategy to obtain future extramural funding.
The funds cannot be used for capital equipment or PI salary support. No indirect or subcontract costs are allowed.
Summary of Submission Requirements
The following components must be included in the application, in the indicated order and in a single PDF file:
Executive Summary (in lay terms)
- Research Plan (maximum 2 pages including figures and tables, with 1 additional page of references)
- Clinical Relevance
- Significance
- Innovation
- Approach
- Timeline for NCI funding submissions
- Budget (use template provided)
- Budget Justification (maximum 1 page)
- Biosketch (current NIH format, maximum 5 pages per PI and key personnel)
Houston Methodist ACADEMIC INSTITUTE President’s Awards Request for Nominations
Key Dates
Nominations Due:
July 29, 2022 at Noon
Awards Announced:
Sept. 1, 2022 Town Hall
Nomination Eligibility Information
Eligible nominees include Houston Methodist-employed faculty with a primary HMAI academic appointment by the time of publication or grant award. Nominees must be in good professional standing with the institution to be nominated. Houston Methodist Department Chairs, Center of Excellence Directors, or Vice-Chairs of Research can nominate any eligible nominee in their department (see attached template). The nominator must be senior to the nominee. No self-nominations are accepted. Additional eligibility requirements, specific to the award, are provided within the award description below, if applicable.
Please note: All Awards are chosen by the HMAI Executive Committee; not all categories are awarded at every Town Hall meeting. Nominations that are not selected cannot be resubmitted.
NIH Competitiveness Award Initiative
Eligible nominees (see eligibility) must have applied for an NIH grant, R01 or equivalent, that was not funded but scored within 10% above the pay line. Award recipients will receive up to $50,000 toward activities that support grant resubmission with the aim to achieve funding success. Unspent funds do not carry over between budget periods. NOTE: Applicants can only receive this award once during their career.
Nominations are accepted on an ongoing basis. Applicants must submit 1) letter of nomination from their Department Chair, Center of Excellence Director, or Vice-Chair of Research, 2) grant summary statement, 3) copy of the grant, 4) proposed NIH resubmission strategy and 5) proposed HM budget to support research activities for NIH resubmission. The resubmission strategy should include a timeline, milestones, goals, and a point-by-point response to the reviewers’ comments. Please reach out to Faculty Development (facultydev@houstonmethodist.org) for assistance with developing a resubmission strategy.
Career Cornerstone Award
Eligible nominees (see eligibility) will have received their first career NIH R01 grant as a Principal Investigator (PI). PIs will receive the equivalent of 50% of the budgeted indirect costs as a discretionary fund for use toward eligible academic activities (excluding capital equipment purchases). For grants with more than one PI, the award amount will be based on the awarded NIH budget for the nominated PI. The discretionary fund will be active for the duration of the original NIH project period. Once the underlying NIH grant ends, use of the discretionary fund will also end. Unspent funds do not carry over between budget periods of the underlying grant project period. NOTE: Nominees can only receive this award for their first R01 grant.
Nominations are accepted as a rolling submission until the listed deadline. Applicants must submit 1) a nomination letter from their Department Chair, Center of Excellence Director, or Vice-Chair of Research, 2) NIH grant award notice, 3) the grant budget and 4) a copy of the grant.
Award for Excellence in Peer-Reviewed Publication
Eligible nominees (see eligibility) include Houston Methodist-employed junior faculty who recently published a manuscript in a high-impact journal, such as New England Journal of Medicine, Journal of the American Medical Association, Lancet, Nature, Cell, Science, or their specialized sister journals. If the manuscript has not yet been published, proof of acceptance must be provided. Faculty members up to Associate Professor listed as first or corresponding author can receive up to $5,000 in discretionary funds toward eligible academic activities. Carryover of unspent funds is not allowed.
Nominations are accepted on an ongoing basis until the listed deadline. Applicants must submit 1) a nomination letter that includes a brief lay summary describing the significance and impact of the work and journal impact factor and 2) a PDF of the manuscript.
Award for Excellence in Transformational Research
Eligible nominees (see eligibility) with recent transformational academic achievements, such as peer-reviewed grant awards with groundbreaking conceptual advances in translational research that strengthen the reputation of Houston Methodist, are eligible for this award. Faculty members listed as PI can receive up to $25,000 in discretionary funds toward eligible academic activities. Carryover of unspent funds is not allowed.
Eligible grants include extramural funding from government or private nonprofit foundations, such as Program Project Grants (e.g., P01, P50, P30, U54, U19) and federally funded Multi-Center Research Grants (e.g., Department of Defense Breast Cancer Research Program: Clinical Translational Research Award). Other examples include the transformational advancement of Houston Methodist technologies into clinical use, including but not limited to exceptional licensing agreements, sponsored research agreements, and externally sponsored clinical trials that support Houston Methodist technologies for commercialization. NOTE: Applicants cannot receive this award in recognition of funding received from intramural programs.
Nominations are accepted on an ongoing basis until the listed deadline. Applicants must submit a nomination letter that includes a brief lay summary describing the significance and impact of the work. For published achievements, nominees should also submit a PDF of the grant and notice of award.
Award for Excellence in Research
Eligible nominees (see eligibility) include Houston Methodist-employed faculty members with recent outstanding academic achievements that show potential to significantly impact clinical translation or scientific innovation. Eligible grants include but are not limited to: funded U01 and R01 awards receiving a high impact score that advance new frontiers in research or bridge a critical gap between basic research and clinical applications. Other examples include licensing agreements and sponsored research agreements that bring technological advances and products into the market and support Houston Methodist technologies for commercialization. Recipients will receive up to $10,000 in discretionary funds for his/her use toward eligible academic activities. Carryover of unspent funds is not allowed.
Nominations are accepted on an ongoing basis until the listed deadline. Applicants must submit a nomination letter that includes a brief lay summary describing the significance and impact of the work. For achievements that were published, nominees should also submit a PDF of grant and notice of award.
Award for Excellence in Education
Eligible nominees (see eligibility) include Houston Methodist-employed faculty members who have demonstrated an ongoing commitment and excellence in teaching, supervision, mentoring, innovation in trainee education or related instructional activities. Nominees will be evaluated and selected for their stellar and enduring contributions to high-quality clinical and translational education that advances the practice of medicine at Houston Methodist. The award will be commensurate with the level of excellence and is at the discretion of the HMAI Executive Leadership.
Stellar and enduring educational contributions include, but are not limited to:
- Educational leadership - Sustained commitment to quality instruction that promotes teaching, engagement and delivery of innovative clinical and translational education
- Innovative teaching methods - Creative, diverse, and innovative teaching strategies and instructional methods that foster patient care, quality and safety, interprofessional and team-based practice, quality education and learning
- Creation of educational programs and materials - Development of training programs, curricula or courses that provide trainees an ‘unparalleled’ learning experience and enhance academic and scholarly activities at Houston Methodist
- Mentoring - Commitment to trainees by providing advising and mentoring that supports trainee success
Houston Methodist Academic Institute 2022 Men of Distinction Annual Award Request for Applications
The Men of Distinction funding opportunity provides support for clinician/research scientist partnerships leading pediatric research, education, and/or patient care programs in the Texas Medical Center or Houston area.
Key Dates
Internal Application Submission Deadline:
Aug. 5, 2022; 12 noon*
HMH Foundation Review:
August – September 2022
Application Due to Men of Distinction:
Oct. 15, 2022
Eligibility
- Any Houston Methodist-employed faculty with a primary HMAI academic appointment is eligible to apply as a Principal Investigator (PI).
- Proposals must include a HM-employed physician and a HM-employed research scientist.
- HM-employed, non-independent researchers (e.g., research scientists, research associates and instructors) are eligible to apply as a co-investigator.
- Proposed programs must focus on research, treatment, education or patient care for children in the Texas Medical Center and the city of Houston.
- One-page narrative including:
- Title of the program
- Name of the organization
- PI contact information (telephone number and email address)
- Statement of need
- Information on how the program will benefit children in Houston, Texas
- An estimate of how many lives will be impacted through this program (i.e., scope of the project)
- A detailed budget of how the grant money will be used (no overhead is allowed)
- One-page (or less) description of the program, in lay terminology
- A brief bio on the researcher(s) and/or physician(s) leading the program (1/2-page max per PI)
Houston Methodist Academic Institute RNA Therapeutics for Cancer Initiative Request for Applications
The Houston Methodist Center for RNA Therapeutics offers rigorous and transformative research strategies and cutting-edge technologies for foundational biological mechanisms in RNA biology and translates this knowledge into novel RNA-based products. This Request for Applications (RFA) solicits research projects that focus on innovative cancer-related projects aimed at developing mRNA-based therapeutics or utilizing mRNA as a tool to study cancer biology. Applications may include a variety of projects, including but not limited to proof-of-concept and high-risk investigational studies.
Key Dates
Internal Application Submission Deadline:
Wednesday, Aug. 17, 2022, at noon*
Committee Review:
August - September 2022
Award Announcement:
September 2022
Estimated Funding Start Date:
Oct. 1, 2022
For additional details and eligibility information, please review the attached RFA. Applications must be received by noon on Wednesday, Aug. 17, 2022, via the Houston Methodist Intramural Awards Portal (https://intramural-awards.houstonmethodist.org/).
Houston Methodist Academic Institute Translational Research Initiative Request for Applications
The Houston Methodist Academic Institute is pleased to announce a new cycle of the Translational Research Initiative (TRI) program, which supports the development of projects that are ready to advance significantly beyond basic laboratory research. The TRI mechanism considers innovations that are ready to enter a product development stage including but not limited to analytical and clinical evaluation, GMP production, GLP studies and/or Phase I or IIa clinical trials.
Key Dates
Applications Due:
Aug. 19, 2022, at noon*
Applications Reviewed:
August 2022 - November 2022
Awards Announced:
November/December 2022
Estimated Funding Start Date:
Jan. 1, 2023
Full details regarding submission requirements can be found in the attached RFA. Applications must be received by noon Aug. 19, 2022, via the Houston Methodist Intramural Awards Portal (https://intramural-awards.houstonmethodist.org/). Direct link to funding opportunity: https://intramural-awards.houstonmethodist.org/#competitionDetail/1847028
*All times CST
Browse previous issues
Contact us at news@houstonmethodist.org
Subscribe to this internal e-newsletter here.
Houston Methodist Academic Institute
6670 Bertner Avenue, Houston, TX 77030
Copyright © 2021 Houston Methodist Academic Institute, All rights reserved.